Scientific name: Vial 16 ML
Scientific name: Bevacizumab
Indications
- Glioblastoma: as a single agent for adult patients with progressive disease following prior therapy
- Glioblastoma: as a single agent for adult patients with progressive disease following prior therapy
- Metastatic renal cell carcinoma with interferon alfa
- Platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: in combination with paclitaxel, pegylated liposomal doxorubicin or topotecan.